1˚ Step ALWAYS IN ANY PT
Determine if pt is SUICIDAL.
If pt is suicidal –> HOSPITALIZE غصب عن أمه
|
Suicide Assessment & Tx of Suicidality
|
|
|
RF
|
SAD PERSONS
· Sex (male)
· Age
· Depression
· Previous attempt
· EtOH or other substances use
· Rational thoughts loss (psychosis)
· Social support lacking
· Organized plan
· No spouse or significantly other
· Sickness or injury
|
|
Assessment
|
Evaluate if pt has the idea:
· Wish to die, not wake up (passive)
· Thought of killing self (active)
· Frequency, duration, intensity, controllability
Evaluate if pt has intent:
· Strength of intent to attempt suicide; ability to control impulsivity
· Determine how close patient has come to acting on a plan (rehearsal, aborted attempts)
Evaluate if pt has a plan:
· Specific details: Method, time, place, access to means (e.g., weapons, pills), preparations (e.g., gathering pills, changing will)
· Lethality of method
Likelihood of rescue
|
|
Management
|
High imminent risk (ideation, intent and plan)
· Ensure safety: Hospitalize immediately (involuntarily if necessary)
· Remove personal belongings and objects in room that may present self-harm risk
· Constant observation and security may be required to hold against will
High non-imminent risk (ideation, intent and no plan to act near future)
· Ensure close follow-up
· Treat modifiable risk factors (underlying depression, psychosis, substance abuse, pain)
· Recruit family or friends to support pt
· Reduce access to potential means (secure firearms, medications)
|
Differential diagnosis of depressed mood:
|
MDD
|
· ≥2 weeks
· ≥5 of 9 of the following symptoms; depressed mood and SIGECAPS
o Loss of interest
o Sleeping
o Anhedonia
o Suicidal
o Low energy
o Appetite
o Concentration ❌
o Psychomotor agitation
o No life-time history of mania
o Significant functional impairment
|
|
Dysthymia
|
· Chronic depressed mood ≥2 years
· ≥2 of the following: appetite disturbance, sleep disturbance, low energy, low self-esteem, poor concentration, hopelessness
|
|
Adjustment disorder w/ depressed mood
|
· Onset within 3 months of identifiable stressor
· Marked distress/ functional impairment
· Can be with depressed mood (but does not meet the criteria of MDD)
|
|
Normal stress response
|
· Not excessive or not out of proportion to severity of stressor
· No significant functional impairment
|
|
Major Depression Disorder
|
|
|
Dx
|
· ≥5 of the following Sx for ≥2 weeks:
o Depressed mood
o Loss of interest or pleasure
o Change in appetite or weight
o Insomnia or hyperinsomnia
o Psychomotor retardation or agitation
o Low energy
o Poor concentration or indecisiveness
o Thoughts of worthlessness or inappropriate guilt
o Recurrent thoughts of death or suicide
· No hx of mania or hypomania
· Not d/t substances or another medical conditions
|
|
Tx
|
· Psychotherapy
· Antidepressant medication
If partial response to antidepressant:
§ Add another💊w/ different MoA
§ 2nd-gen antipsychotic
§ Psychotherapy
§ Lithium
Bupropion (NDIR)
§ Appropriate for weight loss
§ No sexual SE
Special uses:
· Pt wants to sleep better: Trazodone
· Pt wants to GAIN weight: Miratzapine
· Pt wanna quit smoking: Bupropion
|
|
Electroconvulsive
Therapy
|
Indications
· Treatment resistance
· Psychotic features
· Emergency conditions
o Pregnancy
o Refusal to eat or drink
o Imminent risk for suicide
Safety
· No absolute contraindication
· Increased risk
o Severe CV disease, recent MI
o Space-occupying brain lesion
o Recent stroke, unstable aneurysm
|
Anti-depressants 💊:
· Bupropion
o Is a NDRI
o It is associated with increased risk of SZ but less weight gain and sexual side effects than selective serotonin reuptake inhibitors (SSRIs)
· Mirtazapine
o In patients with depression characterized by insomnia and weight loss, mirtazapine is often preferred due to its sedating and appetite-stimulating properties.
· Trazodone
o Is a serotonin modulator that is highly sedating and commonly used lower doses to target insomnia
o It can cause orthostatic hypotension and is associated with the rare but serious side effect of priapism
· Duloxetine
o Serotonin and norepinephrine inhibitor (SNRI), has demonstrated efficacy in treating painful diabetic neuropathy.
o It can also be used as a first line treatment for depression
· SNRIs and TCA (Amitriptyline)
o Booth have been shown to have analgesic properties apart from their antidepressant effects and have a role in treating neuropathy and other chronic pain conditions
|
When to stop tx for MDD?
|
|
· MDD is a recurrent illness for most patients.
· If no recurrence → 6 months of free sx → discontinue tx.
· If ≥2 recurrence → maintainance therapy → longer than 6
· months
· If pt is young, persistant residual sx → maintainance
· therapy → longer than 6 months
However, patients with a hx of highly recurrent
illness (≥3 lifetime depressive episodes), chronic
episodes (≥2 years), severe ongoing psychosocial stressors,
or severe episodes (suicide attempts) are candidates
for maintaining antidepressant tx indefinitely (forever).
|
Antidepressant discontinuation syndrome:
Symptoms
· Dizziness
· Flu-like and GI symptoms
· Tremor
· Neurosensory disturbances (e.g., electric shock, rushing sensation in the head, paresthesia, hyper-responsivity to light and noise, vivid dreams)
The management approach
The best management approach is to re-institute in the same antidepressant and taper the dose gradually over 2-4 weeks or longer in severe cases
|
Serotonin Syn
|
Neuroleptic Malignant Syn
|
Malignant Hyperthermia
|
MAOI crisis
|
|
|
Hx
|
SSRI / TCA
|
Antipsychotics
|
Post-op,
use of anesthetic
|
Tyramine ingestion
|
|
BP
|
⤴️
|
⤴️
|
–
|
⤴️
|
|
T
|
⤴️
|
⤴️
|
⤴️
|
–
|
|
Muscle
|
Tremor, Myoclonus
|
RIGIDITY
|
RIGID
|
–
|
|
DTR
|
⤴️
|
N
|
N
|
–
|
|
Other Sx
|
GI Sx
Dilated pupils
|
Confusion
|
–
|
|
Serotonin Syndrome
|
|
|
features
|
· ⤴️ Serotonin Activity
· Can happen w/: TCAs + SSRIs.
|
|
S/S
|
Vitals:
· tachycardia
· hypertension
· hyperthermia,
PEx:
· agitation,
· ocular clonus,
· tremor,
· akathisia,
· hyperreflexia,
· muscle rigidity,
· dilated pupils.
|
|
Dx
|
Clx
|
|
Tx
|
1. withdrawal of the offending agent
2. benzodiazepines to tx agitation and tremor
3. Cyproheptadine as an antidote
|
|
Serotonin Syndrome
|
|
|
?
|
· Serotonergic medications, especially if combined (SSRI/SNRI, TCA, tramadol)
· Drug interactions; Serotonergic medications and MAOI or linezolid ✳️
· Intentional overdose of serotonergic medications
|
|
Clx
|
· Mental status (Anxiety, agitation, delirium)
· Autonomic dysregulation (diaphoresis, HTN, tachycardia, vomiting, diarrhea)
· Neuromuscular hyperactivity (tremor, myoclonus, hyperreflexia)
|
|
Tx
|
· STOPP of all serotonergic medications
· Supportive care,
· sedation with benzos
· If supportive measures fail: Serotonin antagonist (cyproheptadine)
|
|
Dysthymia
(Chronic Depressed Mood)
|
|
|
Clx
|
· Chronic depressed mood ≥ 2 years
· No Sx-free period >2 months
· Presence of ≥ 2 of:
o Sleep: Insomnia ⤵️ or hypersomnia ⤴️
o Energy: ⤵️
o Self-esteem: ⤵️
o Poor concentration
o Feeling hopeless (less severe than MDD)
|
|
Different Types
|
· Pure dysthymic syndrome: criteria for MDD episode are NEVER ⊕.
· Dysthymia w/ intermittent MDD episodes
· Dysthymia w/ persistent MDD episodes: criteria for MDD episode are ⊕ throughout previous 2 years
|
|
MDD
|
Grief (bereavement)
|
|
• 5 of 9 Sx – 2 Weeks Period:
(Sleep disturbances, appetite (⤴️ or ⤵️), low energy, psychomotor retardation, anhedonia, low mood, feeling guilt, difficulty in concentration, suicidal ideation)
• Low mood or anhedonia must be ⊕
• May occur in response to a variety of stressors, including loss of loved one
• Pt has social & occupational dysfunction
|
• Normal reaction to loss
• Feelings of loss & emptiness
• Sx revolve around the lost one
• Functional decline temporary (intensity ⤵️ over time) & less severe
• “Waves” of grief at reminders
• Less common sx of worthlessness, self-loathing, guilt & suicidality
• Thoughts of dying involve joining the deceased
|
|
Postpartum mood disorder
|
||||
|
⏰
|
Disorder
|
Sx
|
Mother’s Feelings Toward Baby
|
Tx
|
|
2 weeks
|
Postpartum blues or baby blues
|
Sadness, mood lability, tearfulness
|
No negative feelings
|
Supportive usually self-limited
|
|
During pregnancy or
after 4 weeks
|
Depressive disorder with peripartum onset
|
Depressed mood, weight changes, sleep disturbances, and excessive anxiety
|
May have negative feelings toward baby
|
Antidepressant medications
|
|
During pregnancy or
after 4 weeks
|
Bipolar disorder with prepartum onset
Brief psychotic disorder with peripartum onset
|
Symptoms of depression, mania along with delusions, hallucinations and thoughts of harm
|
May have thoughts of harming baby
|
Antipsychotic medication, lithium, and possible antidepressant
|
|
Bipolar Disorder
|
||
|
||
|
Bipolar I:
· Manic episodes
· Depressive episodes common, but not required for diagnosis
|
||
|
Bipolar II:
· Hypomanic episodes
· ≥1 major depressive episodes required
|
||
|
Cyclothymic disorder:
· At least 2 years of fluctuating, mild hypomanic and depressive symptoms that do not meet criteria for hypomanic episodes
Or major depressive episodes
|
|
Bipolar
|
|
|
Nx
|
DSM-5?
|
|
S/S
|
· Mania + Depression
|
|
Dx
|
· Clx
|
|
Tx
|
1˚ ENSURE Pt SAFETY
2˚ Mood stablizer (Lithium)
|
|
Manic Episode
|
|
|
Clx
|
≥1 week of elevated or irritable mood and ⤴️ energy/activity
≥3 of the following sx:
· Distractibility
· Impulsivity/ indiscretion, risky behavior
· Grandiosity
· Flight of ideas/ racing thoughts
· Increased need for sleep
· Talkativeness/ pressured speech (DIGFAST mnemonic)
|
|
Severity
|
· Impaired psychosocial function
· +/- psychosis (hallucinations, delusions)
· May require hospitalization
|
|
Tx
|
· Antipsychotics (first-second-generation)
· Lithium (avoid in renal disease)
· Valproate (avoid in liver disease)
· Combinations in severe mania (antipsychotic plus lithium or valproate)
· Adjunctive benzodiazepines for insomnia, agitation
|
|
Dysthymia
|
Cyclothymia
|
|
light depression for 2 ys
|
· light bipolar for 2 ys
· have mariatel issues
· can be borderline
|
|
respond to psychotherapy
|
Respond to lithium
& psychotherapy
|
|
Lithium Toxicity
|
|
|
?
|
· Overdose
· Volume depletion (⤵️ GFR)
· During interactions (ones that affect the kidney)
o Thiazide
o NSAIDs
o ACE inhibitors
|
|
Sx
|
· Thyroid/ Nephrogenic DI
· Acute
o GI: N/V, diarrhea
o Late neurologic sequelae
· Chronic toxicity (neurologic)
o Ataxia
o Tremors/ fasciculations
|
|
Tx
|
1. Discontinuing: lithium is recommended
2. If you cannot: salt restriction and selected diuretics such as amiloride
3. When to hemodialysis?
o Serum lithium level >4
o Lithium level >2.5 + signs of significant lithium toxicity (e.g., SZ,AMS)
o Inability to excrete lithium (e.g., renal disease, decompensated heart failure.
|
